Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors

被引:77
作者
Kinyamu, HK [1 ]
Chen, J [1 ]
Archer, TK [1 ]
机构
[1] Natl Inst Environm Hlth Sci, Chromat & Gene Express Sect, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1677/jme.1.01680
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Over 25 years ago, eukaryotic cells were shown to contain a highly specific system for the selective degradation of short-lived proteins, this system is known as the ubiquitin-proteasome pathway. In this pathway, proteins are targeted for degradation by covalent modification by a small highly conserved protein named ubiquitin. Ubiquitin-mediated degradation of regulatory proteins plays an important role in numerous cell processes, including cell cycle progression, signal transduction and transcriptional regulation. Recent experiments have shown that the ubiquitin-proteasome pathway is also involved in nuclear hormone receptor (NR)-mediated transcriptional regulation. The idea that the ubiquitin-proteasome pathway is involved in NR-mediated transcription is strengthened by experiments showing that ubiquitin-proteasome components are recruited to NR target gene promoters. However, it is not clear how these components modulate NR-mediated chromatin remodeling and gene expression. In this review, we postulate the role of the ubiquitin-proteasome pathway on NR-mediated chromatin remodeling and gene regulation based on the current knowledge from studies implicating the pathway in chromatin structure modifications that are applicable to NR function. Since evidence from this laboratory, using the glucocorticoid receptor responsive mouse mammary tumor virus (MMTV) promoter organized as chromatin, suggest that the ubiquitin-proteasome system may be involved in the elongation phase of transcription, we particularly concentrate on chromatin modifications associated with the elongation phase.
引用
收藏
页码:281 / 297
页数:17
相关论文
共 191 条
[31]   Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription [J].
Collingwood, TN ;
Urnov, FD ;
Wolffe, AP .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1999, 23 (03) :255-275
[32]   Control of elongation by RNA polymerase II [J].
Conaway, JW ;
Shilatifard, A ;
Dvir, A ;
Conaway, RC .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (08) :375-380
[33]   The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins [J].
Connell, P ;
Ballinger, CA ;
Jiang, JH ;
Wu, YX ;
Thompson, LJ ;
Höhfeld, J ;
Patterson, C .
NATURE CELL BIOLOGY, 2001, 3 (01) :93-96
[34]   Localized recruitment of a chromatin-remodeling activity by an activator in vivo drives transcriptional elongation [J].
Corey, LL ;
Weirich, CS ;
Benjamin, IJ ;
Kingston, RE .
GENES & DEVELOPMENT, 2003, 17 (11) :1392-1401
[35]   Unified nomenclature for the COP9 signalosome and its subunits: an essential regulator of development [J].
Deng, XW ;
Dubiel, WG ;
Wei, N ;
Hofmann, K ;
Mundt, K ;
Colicelli, L ;
Kato, J ;
Naumann, M ;
Segal, D ;
Seeger, M ;
Glickman, M ;
Chamovitz, DA ;
Carr, A .
TRENDS IN GENETICS, 2000, 16 (05) :202-203
[36]   Importance of the regulation of nuclear receptor degradation [J].
Dennis, AP ;
Haq, RU ;
Nawaz, Z .
FRONTIERS IN BIOSCIENCE, 2001, 6 :D954-D959
[37]   Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking [J].
Deroo, BJ ;
Rentsch, C ;
Sampath, S ;
Young, J ;
DeFranco, DB ;
Archer, TK .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (12) :4113-4123
[38]   Glucocorticoid receptor-mediated chromatin remodeling in vivo [J].
Deroo, BJ ;
Archer, TK .
ONCOGENE, 2001, 20 (24) :3039-3046
[39]   Methylation of histone H3 by COMPASS requires ubiquitination of histone H2B by Rad6 [J].
Dover, J ;
Schneider, J ;
Tawiah-Boateng, MA ;
Wood, A ;
Dean, K ;
Johnston, M ;
Shilatifard, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (32) :28368-28371
[40]  
Dressel U, 1999, MOL CELL BIOL, V19, P3383